The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-{4-[(1-Isopropyl-1H-indazole-3-carbonyl)-amino]-piperidin-1-yl}-2,2-dimethylpropionicacid tartarate ID: ALA5283568
Max Phase: Preclinical
Molecular Formula: C25H36N4O9
Molecular Weight: 386.50
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)n1nc(C(=O)NC2CCN(CC(C)(C)C(=O)O)CC2)c2ccccc21.O=C(O)C(O)C(O)C(=O)O
Standard InChI: InChI=1S/C21H30N4O3.C4H6O6/c1-14(2)25-17-8-6-5-7-16(17)18(23-25)19(26)22-15-9-11-24(12-10-15)13-21(3,4)20(27)28;5-1(3(7)8)2(6)4(9)10/h5-8,14-15H,9-13H2,1-4H3,(H,22,26)(H,27,28);1-2,5-6H,(H,7,8)(H,9,10)
Standard InChI Key: DNAJUDQPFHZMBB-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 39 0 0 0 0 0 0 0 0999 V2000
2.8059 2.5450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0098 2.7575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2239 1.9618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2060 2.5822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9526 1.7969 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.5054 1.1837 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2543 0.4016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4472 0.2272 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1968 -0.5589 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.6093 -0.7352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8597 -1.5215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3698 -2.1874 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.8518 -2.8591 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.6394 -2.6081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3581 -3.0257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0730 -2.6128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0720 -1.7851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3600 -1.3724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6443 -1.7815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5923 -3.6424 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1408 -4.2589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2158 -3.8092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1650 -0.1253 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.1095 0.8346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1451 1.6223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2662 3.5408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0730 3.7142 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.7140 4.1541 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.1409 3.5445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5533 2.8300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1409 2.1156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5533 1.4013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3782 1.4013 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.1409 0.6868 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.3159 2.1156 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.3782 2.8300 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.3159 3.5445 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.5533 4.2589 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 2 1 0
5 4 1 0
6 5 1 0
7 6 1 0
8 7 1 0
9 8 1 0
10 9 1 0
11 10 1 0
12 11 2 0
13 12 1 0
14 13 1 0
15 14 2 0
16 15 1 0
17 16 2 0
18 17 1 0
19 18 2 0
19 14 1 0
11 19 1 0
13 20 1 0
20 21 1 0
20 22 1 0
10 23 2 0
8 24 1 0
5 25 1 0
25 24 1 0
2 26 1 0
26 27 1 0
26 28 2 0
29 30 1 0
30 31 1 0
31 32 1 0
32 33 2 0
32 34 1 0
31 35 1 0
30 36 1 0
29 37 2 0
29 38 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 386.50Molecular Weight (Monoisotopic): 386.2318AlogP: 2.92#Rotatable Bonds: 6Polar Surface Area: 87.46Molecular Species: ZWITTERIONHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.37CX Basic pKa: 9.54CX LogP: -0.24CX LogD: -0.24Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.80Np Likeness Score: -1.11
References 1. Nirogi R, Mohammed AR, Shinde AK, Gagginapally SR, Kancharla DM, Ravella SR, Bogaraju N, Middekadi VR, Subramanian R, Palacharla RC, Benade V, Muddana N, Abraham R, Medapati RB, Thentu JB, Mekala VR, Petlu S, Lingavarapu BB, Yarra S, Kagita N, Goyal VK, Pandey SK, Jasti V.. (2021) Discovery and Preclinical Characterization of Usmarapride (SUVN-D4010): A Potent, Selective 5-HT4 Receptor Partial Agonist for the Treatment of Cognitive Deficits Associated with Alzheimer's Disease., 64 (15.0): [PMID:34251799 ] [10.1021/acs.jmedchem.1c00703 ]